Denali Therapeutics (NASDAQ:DNLI) Given New $26.00 Price Target at Wedbush
Denali Therapeutics (NASDAQ:DNLI – Free Report) had its target price cut by Wedbush from $30.00 to $26.00 in a research report released on Friday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other research firms have also recently weighed in on DNLI. Stifel Nicolaus lowered their target price on Denali […]
More Stories
Shanghai Industrial (OTCMKTS:SGHIY) Hits New 12-Month High – Should You Buy?
Shanghai Industrial Holdings Limited (OTCMKTS:SGHIY – Get Free Report)’s stock price hit a new 52-week high on Monday . The...
Napco Security Technologies (NASDAQ:NSSC) Downgraded to Sell Rating by StockNews.com
Napco Security Technologies (NASDAQ:NSSC – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to...
StockNews.com Downgrades Virtus Investment Partners (NASDAQ:VRTS) to Hold
Virtus Investment Partners (NASDAQ:VRTS – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a...
Alarm.com (NASDAQ:ALRM) Upgraded by StockNews.com to “Buy” Rating
Alarm.com (NASDAQ:ALRM – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a...
Eastman Chemical (NYSE:EMN) Downgraded by StockNews.com to Hold
Eastman Chemical (NYSE:EMN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a...
Telefônica Brasil (NYSE:VIV) Cut to Buy at StockNews.com
Telefônica Brasil (NYSE:VIV – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy”...